Senate committee members heard arguments on a bill that would place a 10-year pause on administering mRNA vaccines in Idaho ...
Welcome to the Moderna fourth quarter 2024 conference call. At this time, all participants are in a listen-only mode. After ...
By analyzing ERBB2 mRNA expression data, researchers identified a group of HER2-negative patients with poor outcomes and potential markers of treatment resistance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results